Yanjuan Wang, Lu Hou, Qiaoling Xu, Xiuqing Xue, Jie Pan, Hong Qi, Peng Fang, P. David Mozley, Alton Oliver Sartor, Chunjing Yu. "Phase I dose-escalation results of
                    <sup>177</sup>
                    Lu-NYM032 in patients with progressive metastatic castration-resistant prostate cancer (mCRPC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.5049